Danielle Doedens
Family · Cumming, GANPI 1144661455
Payments from drug & device makers
Across 369 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$894
- Inspire Medical Systems, Inc.$519
- Amgen$485
- Lilly USA, LLC$471
- AstraZeneca$440
- plus $3K from 31 others
What the payments were for
- Food & beverage$7,254100%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 89 | $1,302 |
| Novo Nordisk | 46 | $894 |
| Inspire Medical Systems, Inc. | 20 | $519 |
| Amgen | 21 | $485 |
| Lilly USA, LLC | 23 | $471 |
| AstraZeneca | 23 | $440 |
| GSK | 17 | $415 |
| Pfizer | 16 | $311 |
| Abbott | 14 | $285 |
| Biohaven Pharmaceuticals, Inc. | 4 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $177 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 10 | $159 |
| Exact Sciences | 6 | $119 |
| Boston Scientific | 4 | $119 |
| Dexcom, Inc. | 5 | $116 |
| Idorsia Pharmaceuticals US Inc | 5 | $91 |
| Arbor Pharmaceuticals, Inc. | 5 | $90 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Astellas Pharma US Inc | 3 | $66 |
| Esperion Therapeutics, Inc. | 3 | $65 |
| Amarin Pharma, Inc. | 3 | $53 |
| Genentech USA, Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Currax Pharmaceuticals LLC | 2 | $39 |
| Shield Therapeutics Inc | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Endo Pharmaceuticals Inc. | 2 | $28 |
| Merck | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Linus Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$241
- Repatha$125
- Inspire$124
- MOUNJARO$117
- RYBELSUS$108
How this compares
$7,279 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 77 | $83,599 |
| OzempicSemaglutide | 49 | $46,583 |
| JardianceEmpagliflozin | 44 | $43,227 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $23,412 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 37 | $22,827 |
| TrulicityDulaglutide | 21 | $21,240 |
| FarxigaDapagliflozin Propanediol | 17 | $18,044 |
| BelsomraSuvorexant | 13 | $5,461 |
| SynthroidLevothyroxine Sodium | 25 | $3,143 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $2,241 |
| Eszopiclone | 13 | $2,019 |
| Liothyronine Sodium | 64 | $1,543 |
| UnithroidLevothyroxine Sodium | 14 | $1,520 |
| Colestipol Hcl | 16 | $1,342 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $471 | $104,83998 claims |
| Novo NordiskOzempic | $894 | $46,58349 claims |
| Boehringer IngelheimJardiance | $44 | $43,22744 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $440 | $40,87154 claims |
| GSKTrelegy Ellipta | $415 | $23,41234 claims |
| MerckBelsomra | $22 | $5,46113 claims |
| AbbVieSynthroid | $1,302 | $3,14325 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $15 | $2,30876 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Cumming
- Julia BranchCumming$102K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.